"Medical advances and the efforts of the biopharmaceutical industry over the past several decades have provided society with an unprecedented number and variety of new medicines. Unfortunately, in some cases, these medicines have not reached their therapeutic potential and have left patients underserved. Utilizing our novel technology for improving drug bioavailability, XenoPort is in a unique position to create new medicines that extract the greatest therapeutic benefit from existing, sub-optimal drugs. It is this opportunity to improve the lives of patients that motivates XenoPort's employees to discover, develop and bring to market the medicines of the future."

—Ronald W. Barrett, Ph.D., CEO